NANO-SLIVER ANTI-CANCER COMPOSITION FOR TREATING LUNG CANCER AND PREPARATION METHOD AND USE THEREOF

摘要

Disclosed is a nano-sliver anti-cancer composition for treating lung cancer, containing components at the following concentrations: 12-200 mg/kg of spherical nano-sliver powder, 700-800 mg/kg of a pharmaceutically acceptable dispersant carbomer, 700-800 mg/kg of triethanolamine, and 2.8-3.2g/kg of glucose, wherein the diluent is pure water; the purity of the silver is ≥ 99.99% in the spherical nano-silver powder; and the particle size of the silver particles is 1-5 nm. The composition is used for the complete inhibition of the proliferation of human non-small cell lung cancer cell A549, and causes complete cell death.